Tapinarof
CAS 79338-84-4 7 FDA-DMF suppliersSmall Molecule
Overview
Tapinarof is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL259571).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Tapinarof expires 18 Dec 2039 and exclusivity 12 Dec 2027. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 5-[(E)-2-phenylethenyl]-2-propan-2-ylbenzene-1,3-diol
- Canonical SMILES
- CC(C)C1=C(C=C(C=C1O)/C=C/C2=CC=CC=C2)O
- InChIKey
- ZISJNXNHJRQYJO-CMDGGOBGSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.